시장보고서
상품코드
1301144

골반저근 전기자극기 시장 규모, 점유율, 동향 분석 보고서 : 용도별, 지역별, 부문별 예측(2023-2030년)

Pelvic Floor Electric Stimulator Market Size, Share & Trends Analysis Report By Application (UI, Neurodegenerative Disorders, Sexual Dysfunction), By Region (North America, Asia Pacific), And Segment Forecasts, 2023 - 2030

발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 120 Pages | 배송안내 : 2-10일 (영업일 기준)


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

골반저근 전기자극기 시장 성장 및 동향

GrandView Research, Inc.의 최신 보고서에 따르면 세계의 골반저근 전기 자극기 시장 규모는 2023-2030년 11.9%의 CAGR을 보이고, 2030년까지 5억 3,938만 달러에 달할 것으로 예상됩니다. 전망되고 있습니다.

요실금(UI) 유병률 증가, 주요 기업의 R&D 투자 증가, 인식 제고 구상 증가가 시장 성장을 촉진할 것으로 예상됩니다. NHS에 따르면 남성 인구의 약 61%가 하부 요로 감염을 앓고 있으며, 여성의 약 34%가 UI를 앓고 있는 것으로 나타났습니다. 이 질환으로 인해 NHS는 연간 약 3억 140만 달러의 비용을 부담하고 있습니다. 따라서 시장 성장에 기여하고 있습니다.

또한 노인 인구는 하부 요로에 영향을 미칠 수 있는 뇌졸중, 전립선암, 알츠하이머병과 같은 다양한 신경 질환에 걸릴 위험이 높습니다. 세계보건기구(WHO)에 따르면 세계 65세 이상 인구는 2000년 7.00%에서 2050년 16.00%로 증가할 것으로 예상되며, 이 요인은 이 시장의 높은 성장 촉진요인 중 하나가 될 것으로 예상됩니다. 또한 상대적으로 저렴한 가격대의 기술적으로 진보된 제품 출시가 시장 성장을 가속할 것으로 예상됩니다. 예를 들어 2020년 2월 Atlantic Therapeutics는 시판용 기기 INNOVO(스트레스성 요실금 치료를 위한 착용형 비침습적 골반저근 자극기)의 미국 FDA 승인을 획득했습니다.

골반저근 전기자극기 시장 보고서 하이라이트

  • 용도별로는 세계에서 요실금 환자가 많아 요실금 분야가 2022년 84.9%의 점유율로 시장을 독점했습니다.
  • 북미는 방광폐색, 요실금, 전립선비대증(BPH) 등 대상 질환의 발생률 증가로 인해 2022년 매출 점유율이 38.9%로 가장 높으며 시장을 장악했습니다.
  • 또한 이 지역은 혁신적인 기술과 인프라를 갖춘 세계에서 가장 발전된 지역 중 하나이며, 그 결과 중요한 의료 시설과 환자 치료를 실현하고 있습니다.
  • 그러나 아시아태평양이 2023-2030년 시장을 주도할 것으로 예상됩니다. 고령화, 질 분만, 수술로 인한 여성의 요로감염(UTI) 위험 증가가 이 지역 시장 성장을 주도하고 있습니다.

목차

제1장 조사 방법과 범위

  • 시장 세분화와 범위
  • 조사 방법
  • 정보 조달
  • 정보 또는 데이터 분석
  • 시장 형성과 검증
  • 모델 상세
  • 2차 정보 리스트
  • 1차 정보 리스트
  • 약어 리스트
  • 목적

제2장 주요 요약

  • 시장 전망
  • 부문 전망
  • 경쟁 인사이트

제3장 골반저근 전기 자극기 시장 변수, 동향 및 범위

  • 시장 계통 전망
    • 모시장 전망
    • 보조적 시장 전망
  • 보급과 성장 전망 매핑
  • 주요 최종사용자 리스트
  • 시장 역학
    • 시장 촉진요인 분석
    • 시장 억제요인 분석
  • 골반저근 전기 자극기 : 시장 분석 툴
    • 업계 분석 : Porter의 산업 분석
    • PESTLE 분석
    • 대규모 거래와 전략적 제휴
    • 시장 참여 전략

제4장 골반저근 전기 자극기 시장 : 용도별 부문 분석, 2018-2030년

  • 정의와 범위
  • 용도 시장 점유율 분석, 2022년 및 2030년
  • 부문 대시보드
  • 세계의 골반저근 전기 자극기 시장, 용도별, 2018-2030년
  • 시장 규모, 예측, 동향 분석, 2018-2030년
    • 요실금
    • 신경변성질환
    • 성기능 부전

제5장 골반저근 전기 자극기 시장 : 지역 시장 분석, 용도별, 2018-2030년

  • 정의와 범위
  • 지역 시장 점유율 분석, 2022년 및 2030년
  • 지역 시장 대시보드
  • 지역 시장 스냅숏
  • 시장 규모, 예측, 동향 분석, 2022년과 2030년
  • 북미
    • 국가별, 2018-2030년
    • 제품별,2018-2030
    • 용도별, 2018-2030년
    • 미국
    • 캐나다
  • 유럽
    • 국가별, 2018-2030년
    • 제품별,2018-2030
    • 용도별, 2018-2030년
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 덴마크
    • 스웨덴
    • 노르웨이
  • 아시아태평양
    • 국가별, 2018-2030년
    • 제품별,2018-2030
    • 용도별, 2018-2030년
    • 일본
    • 중국
    • 인도
    • 호주
    • 한국
    • 태국
  • 라틴아메리카
    • 국가별, 2018-2030년
    • 제품별,2018-2030
    • 용도별, 2018-2030년
    • 브라질
    • 멕시코
    • 아르헨티나
  • MEA
    • 국가별, 2018-2030년
    • 제품별,2018-2030
    • 용도별, 2018-2030년
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트
    • 쿠웨이트

제6장 골반저근 전기 자극기 시장 - 경쟁 분석

  • 주요 시장 참여 기업에 의한 최근 동향과 영향 분석
  • 비공개 회사
    • 지역 네트워크 맵
    • 기업의 시장 현황 분석
  • 기업 개요
    • Zynex Medical Inc.
    • Tenscare, Ltd.
    • Verity Medical Ltd
    • Incontrol Medical
    • The Prometheus Group
    • Laborie, Inc.
    • Activlife Technologies Pty Ltd.
    • Athena Feminine Technologies, Inc.
    • Atlantic Therapeutics
    • Renovia Inc.
KSA 23.07.24

Pelvic Floor Electric Stimulator Market Growth & Trends

The global pelvic floor electric stimulator market size is anticipated to reach USD 539.38 million by 2030, registering a CAGR of 11.9% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of Urinary Incontinence (UI), rising investment in research and development by key players, and the growing number of awareness initiatives are anticipated to boost the market growth. Increasing cases of chronic diseases and UI are primary factors that are expected to drive market growth. According to the NHS, around 61% of the male population is suffering from lower urinary tract infections and around 34% of women are living with some type of UI. This disorder costs around USD 301.40 million per year to the NHS. Thereby, contributing to market growth.

Moreover, the geriatric population is at a higher risk for developing various neurological conditions, such as stroke, prostate cancer, and Alzheimer's, which may affect the lower urinary tract. This factor is anticipated to be one of the high growth rendering drivers of this market. As per the WHO, the global population of people aged 65 years and above is expected to rise from 7.00% in 2000 to 16.00% in 2050. This is expected to drive the market at a global level.Furthermore, the launch of technologically advanced products with comparatively lower prices is expected to drive market growth. For instance, in February 2020, Atlantic Therapeutics received U.S. FDA, clearance for the over-the-counter device INNOVO-a wearable and non-invasive pelvic floor muscle stimulator for treating stress urinary incontinence.

Pelvic Floor Electric Stimulator Market Report Highlights

  • Based on the applications, the urinary incontinence segment dominated the market in 2022 with a share of 84.9% owing to the high number of patients suffering from UI globally
  • North America dominated the market with the highest revenue share of 38.9% in 2022 owing to the rising incidence of targeted diseases, such as bladder obstruction, UI, and Benign Prostatic Hyperplasia (BPH)
  • Moreover, this region is one of the most advanced regions globally with innovative technologies & infrastructure, resulting in significant healthcare facilities and patient care
  • However, Asia Pacific is expected to lead the market from 2023 to 2030. The rising risk of Urinary Tract Infection (UTI) in women with increasing age, vaginal deliveries, and surgeries are driving the market growth in this region

Table of Content

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation And Scope
    • 1.1.1 By Application
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
    • 1.6.2 Volume Price Analysis (Model 2)
      • 1.6.2.1 Approach 2: Volume Price Analysis
  • 1.7 List Of Secondary Sources
  • 1.8 List Of Primary Sources
  • 1.9 List Of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Insights

Chapter 3 Pelvic Floor Electric Stimulator Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 List Of Key End Users
  • 3.4 Market Dynamics
    • 3.4.1 Market Driver Analysis
      • 3.4.1.1 Increase In The Prevalence Of Urinary Incontinence
      • 3.4.1.2 Increasing Awareness Initiatives
      • 3.4.1.3 Rise In Geriatric Population
    • 3.4.2 Market Restraints Analysis
      • 3.4.2.1 Availability Of Alternatives
  • 3.5 Pelvic Floor Electric Stimulator: Market Analysis Tools
    • 3.5.1 Industry Analysis - Porter's
    • 3.5.2 Pestle Analysis
    • 3.5.3 Major Deals And Strategic Alliances
      • 3.5.3.1 New Product Launch
      • 3.5.3.2 Acquisition
      • 3.5.3.3 Partnerships
    • 3.5.4 Market Entry Strategies

Chapter 4 Pelvic Floor Electric Stimulator Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 4.1 Definition And Scope
  • 4.2 Application Market Share Analysis, 2022 & 2030
  • 4.3 Segment Dashboard
  • 4.4 Global Pelvic Floor Electric Stimulator Market, By Application, 2018 To 2030
  • 4.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
    • 4.5.1 Urinary Incontinence
      • 4.5.1.1 Urinary Incontinence Market, 2018 - 2030 (USD Million)
    • 4.5.2 Neurodegenerative Disorders
      • 4.5.2.1 Neurodegenerative Disorders Market, 2018 - 2030 (USD Million)
    • 4.5.3 Sexual Dysfunction
      • 4.5.3.1 Sexual Dysfunction Market, 2018 - 2030 (USD Million)

Chapter 5 Pelvic Floor Electric Stimulator Market: Regional Market Analysis, Application, 2018 - 2030 (USD Million)

  • 5.1 Definition & Scope
  • 5.2 Regional Market Share Analysis, 2022 & 2030
  • 5.3 Regional Market Dashboard
  • 5.4 Regional Market Snapshot
  • 5.5 Market Size, & Forecasts, And Trend Analysis, 2022 & 2030
  • 5.6 North America
    • 5.5.1 North America Market Estimates And Forecast, By Country, 2018 - 2030 (USD Million)
    • 5.5.2 North America Pelvic Floor Electric Stimulator Market, By Product, 2018 - 2030 (USD Million)
    • 5.5.3 North America Pelvic Floor Electric Stimulator Market, By Application, 2018 - 2030 (USD Million)
    • 5.5.4 U.S.
      • 5.5.4.1 Key Country Dynamics
      • 5.5.4.2 Regulatory Structure & Reimbursement Framework
      • 5.5.4.3 Competitive Scenario
      • 5.5.4.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
    • 5.5.5 Canada
      • 5.5.5.1 Key Country Dynamics
      • 5.5.5.2 Regulatory Structure & Reimbursement Framework
      • 5.5.5.3 Competitive Scenario
      • 5.5.5.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
  • 5.7 Europe
    • 5.7.1 Europe Pelvic Floor Electric Stimulator Market, By Country, 2018 - 2030 (USD Million)
    • 5.7.2 Europe Pelvic Floor Electric Stimulator Market, By Product, 2018 - 2030 (USD Million)
    • 5.7.3 Europe Pelvic Floor Electric Stimulator Market, By Application, 2018 - 2030 (USD Million)
    • 5.7.4 Uk
      • 5.7.4.1 Key Country Dynamics
      • 5.7.4.2 Regulatory Structure & Reimbursement Framework
      • 5.7.4.3 Competitive Scenario
      • 5.7.4.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
    • 5.7.5 Germany
      • 5.7.5.1 Key Country Dynamics
      • 5.7.5.2 Regulatory Structure & Reimbursement Framework
      • 5.7.5.3 Competitive Scenario
      • 5.7.5.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
    • 5.7.6 France
      • 5.7.6.1 Key Country Dynamics
      • 5.7.6.2 Regulatory Structure & Reimbursement Framework
      • 5.7.6.3 Competitive Scenario
      • 5.7.6.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
    • 5.7.7 Italy
      • 5.7.7.1 Key Country Dynamics
      • 5.7.7.2 Regulatory Structure & Reimbursement Framework
      • 5.7.7.3 Competitive Scenario
      • 5.7.7.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
    • 5.7.8 Spain
      • 5.7.8.1 Key Country Dynamics
      • 5.7.8.2 Regulatory Structure & Reimbursement Framework
      • 5.7.8.3 Competitive Scenario
      • 5.7.8.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
    • 5.7.9 Denmark
      • 5.7.9.1 Key Country Dynamics
      • 5.7.9.2 Regulatory Structure & Reimbursement Framework
      • 5.7.9.3 Competitive Scenario
      • 5.7.9.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
    • 5.7.10 Sweden
      • 5.7.10.1 Key Country Dynamics
      • 5.7.10.2 Regulatory Structure & Reimbursement Framework
      • 5.7.10.3 Competitive Scenario
      • 5.7.10.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
    • 5.7.11 Norway
      • 5.7.11.1 Key Country Dynamics
      • 5.7.11.2 Regulatory Structure & Reimbursement Framework
      • 5.7.11.3 Competitive Scenario
      • 5.7.11.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
  • 5.8 Asia Pacific
    • 5.8.1 Asia Pacific Pelvic Floor Electric Stimulator Market, By Country, 2018 - 2030 (USD Million)
    • 5.8.2 Asia Pacific Pelvic Floor Electric Stimulator Market, By Product, 2018 - 2030 (USD Million)
    • 5.8.3 Asia Pacific Pelvic Floor Electric Stimulator Market, By Application, 2018 - 2030 (USD Million)
    • 5.8.4 Japan
      • 5.8.4.1 Key Country Dynamics
      • 5.8.4.2 Regulatory Structure & Reimbursement Framework
      • 5.8.4.3 Competitive Scenario
      • 5.8.4.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
    • 5.8.5 China
      • 5.8.5.1 Key Country Dynamics
      • 5.8.5.2 Regulatory Structure & Reimbursement Framework
      • 5.8.5.3 Competitive Scenario
      • 5.8.5.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
    • 5.8.6 India
      • 5.8.6.1 Key Country Dynamics
      • 5.8.6.2 Regulatory Structure & Reimbursement Framework
      • 5.8.6.3 Competitive Scenario
      • 5.8.6.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
    • 5.8.7 Australia
      • 5.8.7.1 Key Country Dynamics
      • 5.8.7.2 Regulatory Structure & Reimbursement Framework
      • 5.8.7.3 Competitive Scenario
      • 5.8.7.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
    • 5.8.8 South Korea
      • 5.8.8.1 Key Country Dynamics
      • 5.8.8.2 Regulatory Structure & Reimbursement Framework
      • 5.8.8.3 Competitive Scenario
      • 5.7.8.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
    • 5.8.9 Thailand
      • 5.8.9.1 Key Country Dynamics
      • 5.8.9.2 Regulatory Structure & Reimbursement Framework
      • 5.8.9.3 Competitive Scenario
      • 5.8.9.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
  • 5.9 Latin America
    • 5.9.1 Latin America Pelvic Floor Electric Stimulator Market, By Country, 2018 - 2030 (USD Million)
    • 5.9.2 Latin America Pelvic Floor Electric Stimulator Market, By Product, 2018 - 2030 (USD Million)
    • 5.9.3 Latin America Pelvic Floor Electric Stimulator Market, By Application, 2018 - 2030 (USD Million)
    • 5.9.4 Brazil
      • 5.9.4.1 Key Country Dynamics
      • 5.9.4.2 Regulatory Structure & Reimbursement Framework
      • 5.9.4.3 Competitive Scenario
      • 5.9.4.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
    • 5.9.5 Mexico
      • 5.9.5.1 Key Country Dynamics
      • 5.9.5.2 Regulatory Structure & Reimbursement Framework
      • 5.9.5.3 Competitive Scenario
      • 5.9.5.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
    • 5.9.6 Argentina
      • 5.9.6.1 Key Country Dynamics
      • 5.9.6.2 Regulatory Structure & Reimbursement Framework
      • 5.9.6.3 Competitive Scenario
      • 5.9.6.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
  • 5.10 MEA
    • 5.10.1 MEA Pelvic Floor Electric Stimulator Market, By Country, 2018 - 2030 (USD Million)
    • 5.10.2 MEA Pelvic Floor Electric Stimulator Market, By Product, 2018 - 2030 (USD Million)
    • 5.10.3 MEA Pelvic Floor Electric Stimulator Market, By Application, 2018 - 2030 (USD Million)
    • 5.10.4 South Africa
      • 5.10.4.1 Key Country Dynamics
      • 5.10.4.2 Regulatory Structure & Reimbursement Framework
      • 5.10.4.3 Competitive Scenario
      • 5.10.4.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
    • 5.10.5 Saudi Arabia
      • 5.10.5.1 Key Country Dynamics
      • 5.10.5.2 Regulatory Structure & Reimbursement Framework
      • 5.10.5.3 Competitive Scenario
      • 5.10.5.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
    • 5.10.6 UAE
      • 5.10.6.1 Key Country Dynamics
      • 5.10.6.2 Regulatory Structure & Reimbursement Framework
      • 5.10.6.3 Competitive Scenario
      • 5.10.6.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)
    • 5.10.7 Kuwait
      • 5.10.7.1 Key Country Dynamics
      • 5.10.7.2 Regulatory Structure & Reimbursement Framework
      • 5.10.7.3 Competitive Scenario
      • 5.10.7.4 Pelvic Floor Electric Stimulator Market, 2018 - 2030 (USD Million)

Chapter 6 Pelvic Floor Electric Stimulator Market - Competitive Analysis

  • 6.1 Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2 Private Companies
    • 6.2.1 Regional Network Map
    • 6.2.2 Company Market Position Analysis
  • 6.3 Company Profiles
    • 6.3.1 Zynex Medical Inc.
      • 6.3.1.1 Company Overview
      • 6.3.1.2 Financial Performance
      • 6.3.1.3 Product Benchmarking
      • 6.3.1.4 Strategic Initiatives
    • 6.3.2 Tenscare, Ltd.
      • 6.3.2.1 Company Overview
      • 6.3.2.2 Product Benchmarking
    • 6.3.3 Verity Medical Ltd
      • 6.3.3.1 Company Overview
      • 6.3.3.2 Product Benchmarking
    • 6.3.4 Incontrol Medical
      • 6.3.4.1 Company Overview
      • 6.3.4.2 Product Benchmarking
      • 6.3.4.3 Strategic Intiatives
    • 6.3.5 The Prometheus Group
      • 6.3.5.1 Company Overview
      • 6.3.5.2 Product Benchmarking
      • 6.3.5.3 Strategic Intiatives
    • 6.3.6 Laborie, Inc.
      • 6.3.6.1 Company Overview
      • 6.3.6.2 Product Benchmarking
      • 6.3.6.3 Strategic Intiatives
    • 6.3.7 Activlife Technologies Pty Ltd.
      • 6.3.7.1 Company Overview
      • 6.3.7.2 Product Benchmarking
      • 6.3.7.3 Strategic Intiatives
    • 6.3.8 Athena Feminine Technologies, Inc.
      • 6.3.8.1 Company Overview
      • 6.3.8.2 Product Benchmarking
      • 6.3.8.3 Strategic Intiatives
    • 6.3.9 Atlantic Therapeutics
      • 6.3.9.1 Company Overview
      • 6.3.9.2 Product Benchmarking
      • 6.3.9.3 Strategic Intiatives
    • 6.3.10 Renovia Inc.
      • 6.3.10.1 Company Overview
      • 6.3.10.2 Product Benchmarking
      • 6.3.10.3 Strategic Intiatives
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제